{
  "entitiesById": {
    "afa00": {
      "comments": [
        {
          "content": "5-hydroxytryptamine (serotonin) receptor 2A"
        }
      ],
      "drawAs": "rect",
      "fill": "#ffffff",
      "fontFamily": "Arial",
      "fontSize": 10,
      "fontStyle": "normal",
      "fontWeight": "normal",
      "gpmlElementName": "DataNode",
      "height": 20,
      "id": "afa00",
      "kaavioType": "SingleFreeNode",
      "lineHeight": 1.1,
      "overflow": "hidden",
      "padding": 8,
      "stroke": "#000000",
      "strokeWidth": 1,
      "textAlign": "center",
      "textContent": "HTR2A",
      "textDecoration": "none",
      "textOverflow": "clip",
      "type": [
        "DataNode",
        "SingleFreeNode",
        "Entrez Gene:3356",
        "GeneProduct",
        "Ensembl:ENSG00000102468",
        "P594:ENSG00000102468",
        "P351:3356",
        "HGNC:HTR2A",
        "HTR2A",
        "P353:HTR2A",
        "Wikidata:Q14891424"
      ],
      "verticalAlign": "middle",
      "whiteSpace": "pre",
      "width": 60,
      "wpType": "GeneProduct",
      "x": 58,
      "xrefDataSource": "Entrez Gene",
      "xrefIdentifier": "3356",
      "y": 109,
      "zIndex": 32768
    },
    "b5b37": {
      "citations": [
        "publicationXreff9a"
      ],
      "comments": [
        {
          "content": "Regulation GNAQ --+> JAK2"
        },
        {
          "content": "15640156 (CellLineName: COS-7) Indeed, transfection of a constitutively activated mutant of Galpha(q) (Q209L) in COS-7 cells demonstrated that Galpha(q) is able to associate and activate JAK2."
        }
      ],
      "drawAs": "StraightLine",
      "fill": "none",
      "gpmlElementName": "Interaction",
      "id": "b5b37",
      "isAttachedTo": [
        "cafea",
        "cacda"
      ],
      "kaavioType": "Edge",
      "markerEnd": "MimNecessaryStimulation",
      "points": [
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.25,
              1
            ]
          },
          "isAttachedTo": "cafea",
          "orientation": [
            0,
            1
          ],
          "x": 151,
          "y": 166
        },
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              1,
              0.5
            ]
          },
          "isAttachedTo": "cacda",
          "orientation": [
            -1,
            0
          ],
          "x": 119,
          "y": 192
        }
      ],
      "stroke": "#000000",
      "strokeDasharray": "5,3",
      "strokeWidth": 1,
      "type": [
        "Interaction",
        "Edge"
      ],
      "zIndex": 12288
    },
    "ba2f3": {
      "citations": [
        "publicationXrefcd8",
        "publicationXrefd9a"
      ],
      "comments": [
        {
          "content": "DirectRegulation HTR2A --+> GNAQ"
        },
        {
          "content": "9439849 (Organ: hypothalamic, Tissue: cortex) These results suggest that fluoxetine gradually increases the G-protein coupling of 5-HT2A/2C receptors without altering the levels of Gq- or G11-proteins. \n\n12721328 (Organ: hypothalamic, Tissue: cortex, CellType: neural) These fluoxetine-induced changes in 5-HT2A receptor signaling occur without changing the levels of Galphaq or RGS4 proteins."
        }
      ],
      "drawAs": "StraightLine",
      "fill": "none",
      "gpmlElementName": "Interaction",
      "id": "ba2f3",
      "isAttachedTo": [
        "afa00",
        "cafea"
      ],
      "kaavioType": "Edge",
      "markerEnd": "MimNecessaryStimulation",
      "points": [
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              1,
              0.5
            ]
          },
          "isAttachedTo": "afa00",
          "orientation": [
            1,
            0
          ],
          "x": 118,
          "y": 119
        },
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.25,
              0
            ]
          },
          "isAttachedTo": "cafea",
          "orientation": [
            0,
            1
          ],
          "x": 151,
          "y": 146
        }
      ],
      "stroke": "#000000",
      "strokeWidth": 1,
      "type": [
        "Interaction",
        "Edge"
      ],
      "zIndex": 12288
    },
    "be6b0": {
      "citations": [
        "publicationXrefc21",
        "publicationXrefc0c",
        "publicationXreffee",
        "publicationXreff4e",
        "publicationXrefd34",
        "publicationXreff11",
        "publicationXrefafb"
      ],
      "comments": [
        {
          "content": "Direct Regulation serotonin --+> HTR2A"
        },
        {
          "content": "8808177 (Organ: blood vessel, CellType: neural) Stimulation of the 5-HT2A receptors by serotonin has been reported to exert an excitatory effect on neocortical neurons in rats and mice, to facilitate ischaemia-induced release of excitatory amino acids and to mediate the vasomotor constrictor component of the response of blood vessels to 5-HT. 5-HT2A receptor antagonists have, therefore, been proposed as potential protectants against the effects of cerebral ischaemia. \n\n14654098 (Organ: hippocampal, CellType: neural) High doses of 5-HT also recruited both 5-HT2 and 5-HT3 receptors, causing an increase in the rate and amplitude of sIPSCs. cOA (1 microM), in the presence of Y 25130, failed to potentiate the 5-HT2 receptor induced enhancement of sIPSCs. \n\n11157082 Since 5-HT enhances GABA release ( Liu and Alreja 1997 ), 5-HT2A receptor blockade of clozapine may directly reduce pallidal GABA release. \n\n10431683 Mirtazapine is an atypical antidepressant with alpha 2 adrenergic antagonist and serotonin 5-HT2 and 5-HT3 receptor-blocking activity. \n\n8627578 Neomycin (3 mM) inhibited maximal 5-HT-induced contraction by approximately 50% without inhibiting [3H]5-HT binding to 5-HT2A receptors. \n\n9016798 (Tissue: crypt) Superfusing 5-HT (10 microM) in the bath solution increased both K+ and Cl- currents, which were antagonized by the presence of ketanserin (1 microM), a selective 5-HT2A antagonist, in the bath solution. \n\n9272731 (Tissue: mesangia) The L-type channel blocker verapamil, however, dose-dependently (0.1-10 microM) and specifically inhibited 5-HT-elicited Ca2+ signals by interference with binding of 5-HT to 5-HT2A receptors. 5-HT-mediated Ca2+ release was reduced by 80% when protein kinase C was activated by the phorbolester TPA (0.1 microM)."
        }
      ],
      "drawAs": "StraightLine",
      "fill": "none",
      "gpmlElementName": "Interaction",
      "id": "be6b0",
      "isAttachedTo": [
        "d4a3b",
        "afa00"
      ],
      "kaavioType": "Edge",
      "markerEnd": "Arrow",
      "points": [
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              1
            ]
          },
          "isAttachedTo": "d4a3b",
          "orientation": [
            0,
            1
          ],
          "x": 88,
          "y": 80
        },
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              0
            ]
          },
          "isAttachedTo": "afa00",
          "orientation": [
            0,
            1
          ],
          "x": 88,
          "y": 109
        }
      ],
      "stroke": "#000000",
      "strokeWidth": 1,
      "type": [
        "Interaction",
        "Edge",
        "SBO:0000167",
        "SBO:0000393",
        "SBO:0000394",
        "DirectedInteraction"
      ],
      "zIndex": 12288
    },
    "cacda": {
      "comments": [
        {
          "content": "Janus kinase 2"
        }
      ],
      "drawAs": "rect",
      "fill": "#ffffff",
      "fontFamily": "Arial",
      "fontSize": 10,
      "fontStyle": "normal",
      "fontWeight": "normal",
      "gpmlElementName": "DataNode",
      "height": 20,
      "id": "cacda",
      "kaavioType": "SingleFreeNode",
      "lineHeight": 1.1,
      "overflow": "hidden",
      "padding": 8,
      "stroke": "#000000",
      "strokeWidth": 1,
      "textAlign": "center",
      "textContent": "JAK2",
      "textDecoration": "none",
      "textOverflow": "clip",
      "type": [
        "DataNode",
        "SingleFreeNode",
        "Entrez Gene:3717",
        "GeneProduct",
        "Ensembl:ENSG00000096968",
        "P594:ENSG00000096968",
        "P351:3717",
        "HGNC:JAK2",
        "JAK2",
        "P353:JAK2",
        "Wikidata:Q14914514"
      ],
      "verticalAlign": "middle",
      "whiteSpace": "pre",
      "width": 60,
      "wpType": "GeneProduct",
      "x": 59,
      "xrefDataSource": "Entrez Gene",
      "xrefIdentifier": "3717",
      "y": 182,
      "zIndex": 32768
    },
    "cafea": {
      "comments": [
        {
          "content": "guanine nucleotide binding protein, alpha q polypeptide"
        }
      ],
      "drawAs": "rect",
      "fill": "#ffffff",
      "fontFamily": "Arial",
      "fontSize": 10,
      "fontStyle": "normal",
      "fontWeight": "normal",
      "gpmlElementName": "DataNode",
      "height": 20,
      "id": "cafea",
      "kaavioType": "SingleFreeNode",
      "lineHeight": 1.1,
      "overflow": "hidden",
      "padding": 8,
      "stroke": "#000000",
      "strokeWidth": 1,
      "textAlign": "center",
      "textContent": "GNAQ",
      "textDecoration": "none",
      "textOverflow": "clip",
      "type": [
        "DataNode",
        "SingleFreeNode",
        "Entrez Gene:2776",
        "GeneProduct",
        "Ensembl:ENSG00000156052",
        "P594:ENSG00000156052",
        "P351:2776",
        "HGNC:GNAQ",
        "GNAQ",
        "P353:GNAQ",
        "Wikidata:Q18026236"
      ],
      "verticalAlign": "middle",
      "whiteSpace": "pre",
      "width": 60,
      "wpType": "GeneProduct",
      "x": 136,
      "xrefDataSource": "Entrez Gene",
      "xrefIdentifier": "2776",
      "y": 146,
      "zIndex": 32768
    },
    "ce8ce": {
      "comments": [
        {
          "content": "signal transducer and activator of transcription"
        }
      ],
      "drawAs": "rect",
      "fill": "#ffffff",
      "fontFamily": "Arial",
      "fontSize": 10,
      "fontStyle": "normal",
      "fontWeight": "normal",
      "gpmlElementName": "DataNode",
      "height": 20,
      "id": "ce8ce",
      "kaavioType": "SingleFreeNode",
      "lineHeight": 1.1,
      "overflow": "hidden",
      "padding": 8,
      "stroke": "#000000",
      "strokeWidth": 1,
      "textAlign": "center",
      "textContent": "STAT3",
      "textDecoration": "none",
      "textOverflow": "clip",
      "type": [
        "DataNode",
        "SingleFreeNode",
        "Entrez Gene:6774",
        "GeneProduct",
        "Ensembl:ENSG00000168610",
        "P594:ENSG00000168610",
        "P351:6774",
        "HGNC:STAT3",
        "STAT3",
        "P353:STAT3",
        "Wikidata:Q14912019"
      ],
      "verticalAlign": "middle",
      "whiteSpace": "pre",
      "width": 60,
      "wpType": "GeneProduct",
      "x": 59,
      "xrefDataSource": "Entrez Gene",
      "xrefIdentifier": "6774",
      "y": 236,
      "zIndex": 32768
    },
    "d2154": {
      "citations": [
        "publicationXrefb19"
      ],
      "comments": [
        {
          "content": "Binding HTR2A ---- JAK2"
        },
        {
          "content": "9169451 The blot showing 5-HT 2A receptor-Jak2 kinase association (Fig. 3 A ) was stripped and reprobed with anti-STAT3 antibody."
        }
      ],
      "drawAs": "StraightLine",
      "fill": "none",
      "gpmlElementName": "Interaction",
      "id": "d2154",
      "isAttachedTo": [
        "afa00",
        "cacda"
      ],
      "kaavioType": "Edge",
      "markerEnd": "MimStimulation",
      "points": [
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              1
            ]
          },
          "isAttachedTo": "afa00",
          "orientation": [
            0,
            1
          ],
          "x": 88,
          "y": 129
        },
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              0
            ]
          },
          "isAttachedTo": "cacda",
          "orientation": [
            0,
            1
          ],
          "x": 89,
          "y": 182
        }
      ],
      "stroke": "#cc00cc",
      "strokeWidth": 1,
      "type": [
        "Interaction",
        "Edge"
      ],
      "zIndex": 12288
    },
    "d4a3b": {
      "drawAs": "rect",
      "fill": "#ffffff",
      "fontFamily": "Arial",
      "fontSize": 10,
      "fontStyle": "normal",
      "fontWeight": "normal",
      "gpmlElementName": "DataNode",
      "height": 20,
      "id": "d4a3b",
      "kaavioType": "SingleFreeNode",
      "lineHeight": 1.1,
      "overflow": "hidden",
      "padding": 8,
      "stroke": "#0000ff",
      "strokeWidth": 1,
      "textAlign": "center",
      "textContent": "Serotonin",
      "textDecoration": "none",
      "textOverflow": "clip",
      "type": [
        "DataNode",
        "SingleFreeNode",
        "CAS:50-67-9",
        "Metabolite",
        "ChEBI:CHEBI:28790",
        "ChEBI:28790",
        "P683:CHEBI:28790",
        "P683:28790",
        "HMDB:HMDB0000259",
        "HMDB:HMDB00259",
        "P2057:HMDB0000259",
        "P2057:HMDB00259",
        "Wikidata:Q167934"
      ],
      "verticalAlign": "middle",
      "whiteSpace": "pre",
      "width": 60,
      "wpType": "Metabolite",
      "x": 58,
      "xrefDataSource": "CAS",
      "xrefIdentifier": "50-67-9",
      "y": 60,
      "zIndex": 32768
    },
    "fe91c": {
      "citations": [
        "publicationXrefbfb",
        "publicationXrefd8d",
        "publicationXreffe9",
        "publicationXrefa3c",
        "publicationXrefaa9",
        "publicationXrefe0c",
        "publicationXrefe51"
      ],
      "comments": [
        {
          "content": "Prot Modification JAK2 --+> STAT3"
        },
        {
          "content": "15156153 Hes proteins associate with JAK2 and STAT3, and facilitate complex formation between JAK2 and STAT3, thus promoting STAT3 phosphorylation and activation. \n\n15688010 Tkip also inhibited constitutive (DU145) and IL-6-induced (LNCaP) activation of STAT3, consistent with the fact that STAT3 activation is mediated by JAK2. \n\n11708838 (Organ: heart, CellLineName: IPC) The results demonstrated extensive phosphorylation of JAK2 and STAT3 in the IPC hearts which was almost completely abolished by an inhibitor of JAK2, AG490. \n\n15155836 (Organ: kidney, CellLineName: 293) Inhibition of c-Src and Janus kinase 2 and 3 activities abolished STAT3 activation induced by Galpha14QL, but no physical association between Galpha14QL and c-Src could be detected by coimmunoprecipitation. \n\n15650183 (Organ: liver) Using a series of inhibitors and dominant negative mutants, we show that HCV-induced activation of STAT-3 is mediated by oxidative stress and influenced by the activation of cellular kinases, including p38 mitogen-activated protein kinase, JNK, JAK-2, and Src. \n\n15151905 (Tissue: endothelial) IL-6 treatment increased the phosphorylation of JAK2, an upstream activator of STAT3. \n\n10891587 (Organ: brain, Tissue: glia, CellType: neural) The PSD fraction also had a janus kinase 2 (Jak2)-like molecule, Jak2, believed to phosphorylate Stat3."
        }
      ],
      "drawAs": "StraightLine",
      "fill": "none",
      "gpmlElementName": "Interaction",
      "id": "fe91c",
      "isAttachedTo": [
        "cacda",
        "ce8ce"
      ],
      "kaavioType": "Edge",
      "markerEnd": "MimNecessaryStimulation",
      "points": [
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              1
            ]
          },
          "isAttachedTo": "cacda",
          "orientation": [
            0,
            1
          ],
          "x": 89,
          "y": 202
        },
        {
          "attachmentDisplay": {
            "offset": [
              0,
              0
            ],
            "position": [
              0.5,
              0
            ]
          },
          "isAttachedTo": "ce8ce",
          "orientation": [
            0,
            1
          ],
          "x": 89,
          "y": 236
        }
      ],
      "stroke": "#999900",
      "strokeWidth": 1,
      "type": [
        "Interaction",
        "Edge"
      ],
      "zIndex": 12288
    },
    "http://identifiers.org/cl/CL:0000540": {
      "gpmlElementName": "openControlledVocabulary",
      "id": "http://identifiers.org/cl/CL:0000540",
      "ontology": "Cell Type",
      "term": "neuron",
      "type": [
        "openControlledVocabulary"
      ],
      "xrefIdentifier": "CL:0000540"
    },
    "http://identifiers.org/pw/PW:0000854": {
      "gpmlElementName": "openControlledVocabulary",
      "id": "http://identifiers.org/pw/PW:0000854",
      "ontology": "Pathway Ontology",
      "term": "serotonin signaling pathway",
      "type": [
        "openControlledVocabulary"
      ],
      "xrefIdentifier": "PW:0000854"
    },
    "publicationXrefa3c": {
      "authors": [
        "Lo RK",
        "Wong YH"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefa3c",
      "source": "Mol Pharmacol",
      "standardName": "Signal transducer and activator of transcription 3 activation by the delta-opioid receptor via Galpha14 involves multiple intermediates.",
      "textContent": "12",
      "type": [
        "PublicationXref",
        "PubMed:15155836",
        "Wikidata:Q44345537"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15155836",
      "year": 2004
    },
    "publicationXrefaa9": {
      "authors": [
        "Waris G",
        "Turkson J",
        "Hassanein T",
        "Siddiqui A"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefaa9",
      "source": "J Virol",
      "standardName": "Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication.",
      "textContent": "18",
      "type": [
        "PublicationXref",
        "PubMed:15650183",
        "Wikidata:Q33717232"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15650183",
      "year": 2005
    },
    "publicationXrefafb": {
      "authors": [
        "Goppelt-Struebe M",
        "Stroebel M"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefafb",
      "source": "Naunyn Schmiedebergs Arch Pharmacol",
      "standardName": "Mechanisms of serotonin-induced Ca2+ responses in mesangial cells.",
      "textContent": "6",
      "type": [
        "PublicationXref",
        "PubMed:9272731",
        "Wikidata:Q28609372"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "9272731",
      "year": 1997
    },
    "publicationXrefb19": {
      "authors": [
        "Guillet-Deniau I",
        "Burnol AF",
        "Girard J"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefb19",
      "source": "J Biol Chem",
      "standardName": "Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway.",
      "textContent": "5",
      "type": [
        "PublicationXref",
        "PubMed:9169451",
        "Wikidata:Q28609579"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "9169451",
      "year": 1997
    },
    "publicationXrefbfb": {
      "authors": [
        "Kamakura S",
        "Oishi K",
        "Yoshimatsu T",
        "Nakafuku M",
        "Masuyama N",
        "Gotoh Y"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefbfb",
      "source": "Nat Cell Biol",
      "standardName": "Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling.",
      "textContent": "14",
      "type": [
        "PublicationXref",
        "PubMed:15156153",
        "Wikidata:Q28262816"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15156153",
      "year": 2004
    },
    "publicationXrefc0c": {
      "authors": [
        "Dougalis A",
        "Lees G",
        "Ganellin CR"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefc0c",
      "source": "Neuropharmacology",
      "standardName": "The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro.",
      "textContent": "13",
      "type": [
        "PublicationXref",
        "PubMed:14654098",
        "Wikidata:Q28609346"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "14654098",
      "year": 2004
    },
    "publicationXrefc21": {
      "authors": [
        "Piera MJ",
        "Beaughard M",
        "Michelin MT",
        "Winslow E",
        "Massingham R"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefc21",
      "source": "Fundam Clin Pharmacol",
      "standardName": "Lack of efficacy of 5-HT2A receptor antagonists to reduce brain damage after 3 minutes of transient global cerebral ischaemia in gerbils.",
      "textContent": "1",
      "type": [
        "PublicationXref",
        "PubMed:8808177",
        "Wikidata:Q28609368"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "8808177",
      "year": 1995
    },
    "publicationXrefcd8": {
      "authors": [
        "Li Q",
        "Muma NA",
        "Battaglia G",
        "Van de Kar LD"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefcd8",
      "source": "Brain Res",
      "standardName": "Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins.",
      "textContent": "3",
      "type": [
        "PublicationXref",
        "PubMed:9439849",
        "Wikidata:Q28609374"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "9439849",
      "year": 1997
    },
    "publicationXrefd34": {
      "authors": [
        "Cox DA",
        "Watts SW",
        "Cohen ML"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefd34",
      "source": "J Pharmacol Exp Ther",
      "standardName": "Neomycin selectively inhibits 5-hydroxytryptamine-induced contraction in the guinea pig trachea.",
      "textContent": "2",
      "type": [
        "PublicationXref",
        "PubMed:8627578"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "8627578",
      "year": 1996
    },
    "publicationXrefd8d": {
      "authors": [
        "Flowers LO",
        "Subramaniam PS",
        "Johnson HM"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefd8d",
      "source": "Oncogene",
      "standardName": "A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.",
      "textContent": "17",
      "type": [
        "PublicationXref",
        "PubMed:15688010",
        "Wikidata:Q40462635"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15688010",
      "year": 2005
    },
    "publicationXrefd9a": {
      "authors": [
        "Damjanoska KJ",
        "Van de Kar LD",
        "Kindel GH",
        "Zhang Y",
        "D'Souza DN",
        "Garcia F",
        "Battaglia G",
        "Muma NA"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefd9a",
      "source": "J Pharmacol Exp Ther",
      "standardName": "Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.",
      "textContent": "11",
      "type": [
        "PublicationXref",
        "PubMed:12721328",
        "Wikidata:Q44422939"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "12721328",
      "year": 2003
    },
    "publicationXrefe0c": {
      "authors": [
        "Ni CW",
        "Hsieh HJ",
        "Chao YJ",
        "Wang DL"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefe0c",
      "source": "Am J Physiol Cell Physiol",
      "standardName": "Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow.",
      "textContent": "15",
      "type": [
        "PublicationXref",
        "PubMed:15151905",
        "Wikidata:Q44902169"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15151905",
      "year": 2004
    },
    "publicationXrefe51": {
      "authors": [
        "Murata S",
        "Usuda N",
        "Okano A",
        "Kobayashi S",
        "Suzuki T"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXrefe51",
      "source": "Brain Res Mol Brain Res",
      "standardName": "Occurrence of a transcription factor, signal transducer and activators of transcription 3 (Stat3), in the postsynaptic density of the rat brain.",
      "textContent": "8",
      "type": [
        "PublicationXref",
        "PubMed:10891587",
        "Wikidata:Q28609415"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "10891587",
      "year": 2000
    },
    "publicationXreff11": {
      "authors": [
        "Imada-Shirakata Y",
        "Kotera T",
        "Ueda S",
        "Okuma M"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXreff11",
      "source": "Biochem Biophys Res Commun",
      "standardName": "Serotonin activates electrolyte transport via 5-HT2A receptor in rat colonic crypt cells.",
      "textContent": "4",
      "type": [
        "PublicationXref",
        "PubMed:9016798",
        "Wikidata:Q73031361"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "9016798",
      "year": 1997
    },
    "publicationXreff4e": {
      "authors": [
        "Boyarsky BK",
        "Haque W",
        "Rouleau MR",
        "Hirschfeld RM"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXreff4e",
      "source": "Depress Anxiety",
      "standardName": "Sexual functioning in depressed outpatients taking mirtazapine.",
      "textContent": "7",
      "type": [
        "PublicationXref",
        "PubMed:10431683",
        "Wikidata:Q28609318"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "10431683",
      "year": 1999
    },
    "publicationXreff9a": {
      "authors": [
        "Ferrand A",
        "Kowalski-Chauvel A",
        "Bertrand C",
        "Escrieut C",
        "Mathieu A",
        "Portolan G",
        "Pradayrol L",
        "Fourmy D",
        "Dufresne M",
        "Seva C"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXreff9a",
      "source": "J Biol Chem",
      "standardName": "A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor models.",
      "textContent": "16",
      "type": [
        "PublicationXref",
        "PubMed:15640156",
        "Wikidata:Q40473455"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "15640156",
      "year": 2005
    },
    "publicationXreffe9": {
      "authors": [
        "Hattori R",
        "Maulik N",
        "Otani H",
        "Zhu L",
        "Cordis G",
        "Engelman RM",
        "Siddiqui MA",
        "Das DK"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXreffe9",
      "source": "J Mol Cell Cardiol",
      "standardName": "Role of STAT3 in ischemic preconditioning.",
      "textContent": "10",
      "type": [
        "PublicationXref",
        "PubMed:11708838",
        "Wikidata:Q43799529"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "11708838",
      "year": 2001
    },
    "publicationXreffee": {
      "authors": [
        "Butts DA",
        "Rokhsar DS"
      ],
      "gpmlElementName": "PublicationXref",
      "id": "publicationXreffee",
      "source": "J Neurosci",
      "standardName": "The information content of spontaneous retinal waves.",
      "textContent": "9",
      "type": [
        "PublicationXref",
        "PubMed:11157082",
        "Wikidata:Q28609335"
      ],
      "xrefDataSource": "PubMed",
      "xrefIdentifier": "11157082",
      "year": 2001
    }
  },
  "pathway": {
    "@context": [
      "https://cdn.rawgit.com/wikipathways/WpVocabularies/7a46a05/contexts/pvjs.jsonld",
      {
        "@base": "WP733/"
      }
    ],
    "author": "[Aruke, Khanspers, MaintBot, AlexanderPico, Thomas, Egonw, IreneHemel, Eweitz]",
    "comments": [
      {
        "content": "Source: Ariadne Genomics Pathway Studio.\n\nProteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP733 CPTAC Assay Portal]",
        "source": "WikiPathways-description"
      }
    ],
    "contains": [
      "b5b37",
      "ba2f3",
      "be6b0",
      "d2154",
      "fe91c",
      "afa00",
      "cacda",
      "cafea",
      "ce8ce",
      "d4a3b"
    ],
    "dataSourceVersion": "WP733_r120590",
    "displayName": "Serotonin receptor 2 and STAT3 signaling",
    "drawAs": "rect",
    "fill": "white",
    "fontSize": 12,
    "fontWeight": "bold",
    "gpmlElementName": "Pathway",
    "height": 286,
    "id": "WP733",
    "kaavioType": "Group",
    "name": "Serotonin receptor 2 and STAT3 signaling",
    "organism": "Homo sapiens",
    "padding": 5,
    "pathwayVersion": "WP733",
    "standardName": "Serotonin receptor 2 and STAT3 signaling",
    "stroke": "black",
    "strokeWidth": 0,
    "textAlign": "left",
    "textContent": "Name: Serotonin receptor 2 and STAT3 signaling\nOrganism: Homo sapiens",
    "type": [
      "Pathway",
      "http://identifiers.org/pw/PW:0000854"
    ],
    "verticalAlign": "top",
    "width": 226,
    "x": 0,
    "y": 0,
    "zIndex": 0
  }
}
